Biosimilar Drug Product

By Anonymous (not verified), 8 August, 2025
Short Description

It’s a type of biological medicine that closely resembles an already approved reference product, with no significant differences in safety, effectiveness, or how it works in the body.Its approval pathway relies on demonstrating this similarity.